| scholarly article | Q13442814 |
| P50 | author | John Ioannidis | Q6251482 |
| P2093 | author name string | Moutsopoulos HM | |
| Kokori SI | |||
| Tzioufas AG | |||
| Voulgarelis M | |||
| Kyriaki D | |||
| P2860 | cites work | Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus. Correlation with anemia | Q73994661 |
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus | Q33384656 | ||
| Complement activation by anticardiolipin antibodies | Q33388763 | ||
| Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. | Q33435725 | ||
| Anticardiolipin and complement activation: relation to clinical symptoms | Q33454570 | ||
| Systemic lupus erythematosus and myelofibrosis. | Q33456508 | ||
| Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus | Q33490768 | ||
| Haematological manifestations of systemic lupus erythematosus. | Q33492384 | ||
| Hematologic aspects of systemic lupus erythematosus. Current concepts | Q33493839 | ||
| Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients | Q33499605 | ||
| Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes | Q34627104 | ||
| Progress in understanding the pathogenesis of the anemia of chronic disease | Q35362746 | ||
| Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activ | Q35572124 | ||
| Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic disease | Q36789762 | ||
| Inadequate erythropoietin response to anemia: definition and clinical relevance | Q40665295 | ||
| The acute lupus hemophagocytic syndrome | Q40751248 | ||
| Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposition of iron | Q41522193 | ||
| Effect of inflammatory cytokines on hypoxia-induced erythropoietin production | Q41629121 | ||
| Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin | Q43605580 | ||
| Pernicious anemia in Latin Americans is not a disease of the elderly | Q45261260 | ||
| Circulating autoantibodies to erythropoietin are associated with human immunodeficiency virus type 1-related anemia | Q45746348 | ||
| Prevalence of undiagnosed pernicious anemia in the elderly | Q46101311 | ||
| Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias | Q46748070 | ||
| Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin | Q52400816 | ||
| Acute sideroblastic anemia in active systemic lupus erythematosus. | Q54494365 | ||
| Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome | Q57089786 | ||
| HLA-Dr+ T cells of the Leu 3 (helper) type infiltrate the kidneys of patients with systemic lupus erythematosus | Q58831907 | ||
| Autoimmune hemolytic anemia and periodic pure red cell aplasia in systemic lupus erythematosus | Q67374042 | ||
| Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon | Q67728509 | ||
| Systemic lupus erythematosus and pernicious anemia in an 82-year-old woman | Q67865346 | ||
| Anemia of chronic disease | Q68114045 | ||
| Antiphospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs' and hypocomplementemia | Q68294585 | ||
| Don't Ignore Low Serum Cobalamin (Vitamin B12) Levels | Q68462452 | ||
| High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population | Q68830769 | ||
| Enzyme immunoassays for the detection of IgG and IgM anti-dsDNA antibodies: clinical significance and specificity | Q68835780 | ||
| An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia | Q69662907 | ||
| Pernicious anemia and systemic lupus erythematosus in a young woman | Q69874750 | ||
| Reactivity patterns of anti-phospholipid antibodies in systemic lupus erythematosus sera in relation to erythrocyte binding and complement activation | Q70176992 | ||
| Autoantibodies against erythropoietin in a patient with pure red-cell aplasia | Q70980140 | ||
| The role of anticardiolipin autoantibodies in the pathogenesis of autoimmune hemolytic anemia in systemic lupus erythematosus | Q72023253 | ||
| Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients | Q72768208 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| erythropoietin | Q218706 | ||
| P304 | page(s) | 217-222 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin | |
| P478 | volume | 59 |
| Q43991209 | An uncommon cause of anemia in systemic lupus erythematosus |
| Q33434449 | Anaemia in Systemic Lupus Erythematosus Based on Iron Studies and Soluble Transferrin Receptor Levels |
| Q38059457 | Anaemia in inflammatory rheumatic diseases |
| Q24675466 | Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment |
| Q47167658 | Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study |
| Q39534079 | Anti-erythropoietin receptor antibodies in systemic lupus erythematosus patients with anemia |
| Q33396421 | Associations of serum urea, creatinine and uric acid with clinical and laboratory features in patients with systemic lupus erythematosus |
| Q39245022 | Autoantibodies to erythropoietin receptor in patients with immune‐mediated diseases: relationship to anaemia with erythroid hypoplasia |
| Q38237868 | Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus |
| Q33394969 | Clinical Assessment and Management of Cytopenias in Lupus Patients |
| Q44480207 | Decreased serum level of IL-21 in new-onset systemic lupus erythematosus patients |
| Q90232624 | Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease |
| Q48459103 | Haralampos M. Moutsopoulos: A lifetime in autoimmunity |
| Q33411323 | Hematological disorders in patients with systemic lupus erythematosus |
| Q33375520 | Hematological presentation in systemic lupus erythematosus and its relationship with disease activity |
| Q58700150 | Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease |
| Q33406268 | Management of immune cytopenias in patients with systemic lupus erythematosus — Old and new |
| Q37686499 | Multiple autoimmune syndromes associated with psoriasis: a rare clinical presentation |
| Q84811722 | Nutritional status and food intake in patients with systemic lupus erythematosus |
| Q44383474 | Pure red cell aplasia in a Sjögren's syndrome/lupus erythematosus overlap patient |
| Q38374309 | Reviewing the recommendations for lupus in children |
| Q34990055 | Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome |
| Q28072610 | The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus |
| Q37947986 | The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab. |
| Q37558525 | The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon |
| Q40425520 | Toward Clinical use of the IgG Specific Enzymes IdeS and EndoS against Antibody-Mediated Diseases |
| Q33342024 | Treatment options for juvenile-onset systemic lupus erythematosus |
| Q39150632 | Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. |
| Q33358201 | Visceral leishmaniasis resembling systemic lupus erythematosus |
| Q58004028 | Vulvite par carence en fer |
Search more.